Cervical cancer screening company TruScreen faces trading suspension for late annual report

Cervical cancer screening company TruScreen faces trading suspension for late annual report
Martin Dillon was reappointed chief executive of TruScreen in March. (Image: TruScreen)
Rebecca Stevenson
Cancer screening company TruScreen must file its late annual report by July 8 or face a trading suspension. In a notice to the New Zealand Exchange (NZX), market watchdog NZX RegCo said the firm should have filed its annual report by July 1. NZ RegCo said that because TruScreen missed that deadline, it had five business days following July 1 to publish the report to the NZX. If the report is not published, share trading for TruScreen will be suspended from the market from opening on Tuesday, July 9, until it is filed.TruScreen sh...

More Markets

Robust update from Tauranga Port perks up NZX
Markets Market close

Robust update from Tauranga Port perks up NZX

Numbers hide 'a lot of paddling' going on under the surface. 

Graham Skellern 25 Oct 2024
Jarden upgrades Michael Hill ahead of Christmas
Finance

Jarden upgrades Michael Hill ahead of Christmas

Since a Wednesday trading update, company's shares have risen 9%.

Gregor Thompson 25 Oct 2024
NZ Windfarms buys NZ's oldest windfarm
Infrastructure

NZ Windfarms buys NZ's oldest windfarm

Bottom end of ebitdaf guidance is $1.5m higher than previous estimate.

John Anthony 25 Oct 2024
FMA takes a drubbing from stakeholders
Finance

FMA takes a drubbing from stakeholders

Minor offences are said to be prioritised over poor broking house behaviours.

Pattrick Smellie 25 Oct 2024